Sinopharm Xinguan vaccine approved for use in Hungary

Hungary’s chief medical officer Miller Cecilia announced on the 29th that the new crown vaccine produced by Sinopharm has been approved for use in Hungary.

Miller announced the news at a news conference on the same day. She said that the Hungarian National Institute of pharmacy and nutrition passed the approval of the new crown vaccine produced by Sinopharm on the 29th.

Sinopharm Xinguan vaccine approved for use in Hungary shows Sinopharm Xinguan inactivated vaccine. (China News Agency)

Hungarian prime minister Orban said in an interview with local media earlier in the day that he was very confident in China’s new vaccine.

Data released by the Hungarian Center for new crown epidemic prevention and control on the 29th showed that in the past 24 hours, 1459 new cases were confirmed, with a total of 364909 confirmed cases; 83 new deaths, with a total of 12374 deaths; and 254783 cured cases.

Editor in charge: Lin Wei

留下评论

您的电子邮箱地址不会被公开。 必填项已用*标注